
Laura Alaimo
@LauraAlaimo5
Followers
131
Following
254
Media
7
Statuses
111
MD - University of Catania. General Surgeon & PhD Student - University of Verona. Research Fellow - Ohio State University.
Verona, Veneto
Joined March 2021
RT @NuhNRahbari: 🤖 It was a pleasure to host the 𝟐𝐧𝐝 𝐌𝐚𝐬𝐭𝐞𝐫𝐜𝐥𝐚𝐬𝐬 𝐑𝐨𝐛𝐨𝐭𝐢𝐜 𝐋𝐢𝐯𝐞𝐫 𝐒𝐮𝐫𝐠𝐞𝐫𝐲 this week in Ulm with a fantastic group of surgeons….
0
1
0
Incredibly grateful to ILLS2025 in Seoul! 👉Unforgettable experience both scientifically & personally.👉Extraordinary surgeons to meet.👉True honored to receive the Travel Grant and present some of the scientific work from @HPBVerona @ARuzzenente .Thank you @ILLS_LAPLIVER !
0
1
5
RT @OAE_JCMT: 🚀 Updates on the management of neuroendocrine liver metastasis (NELM). 👉 Latest insights on diagnosis, surgery, systemic ther….
0
4
0
RT @gio_catalano: 🚨 Excited to share @OhioStateSurg latest paper!. 🔎Can machine learning help assess MILS complexity for HCC?. 📋Tumor, surg….
0
3
0
RT @gio_catalano: 🚨 New publication alert!. 📊 What's the best method to evaluate surgical care quality?.🎯 The mDOOR was associated with sur….
0
2
0
RT @gio_catalano: Check out @OhioStateSurg TEAM's latest in @JournalofGISurg!. ⚠️1 in 3 patients developed recurrence after GBC surgery.🫁Pa….
0
4
0
RT @conci_simone: Laparoscopic Sg8 Segmentectomy with cranio-caudal approach: is it the “new” standard tecniques or just a passing trend? h….
0
7
0
RT @conci_simone: A very nice meeting was held yesterday in Verona between high level surgeons but above all between friends from Tirol, Sü….
0
3
0
RT @AnnSurgOncol: #AudioVisualAbstract : Benchmarks in #LiverResection for Intrahepatic #Cholangiocarcinoma @LauraAlaimo5 @timpawlik @Yutak….
0
10
0
RT @timpawlik: Bittersweet visit to @UniVerona DoS 🇮🇹 to participate in the dedication of a conference room in the name of my dear friend a….
0
6
0
RT @conci_simone: How to predict the risk of early recurrence in peri-hilar cholangiocarcinoma? . Try the Preoperative Recurrence Score!!!….
0
8
0
RT @BMC_series: Warm welcome to our new #BMCSurg Editorial Board Members @SavvasLampridis and @LauraAlaimo5. We are looking forward to work….
0
1
0
🔢How many subtypes of intrahepatic cholangiocarcinoma do you know? . 👩🔬Multi-omics analyses help answer the question. 🥼What about the clinical characteristics?. Check out the Systematic Review from our team at @HPBVerona @ARuzzenente . 🔎
www.mdpi.com
Intrahepatic cholangiocarcinoma (ICC) is a heterogeneous disease characterized by a dismal prognosis. Various attempts have been made to classify ICC subtypes with varying prognoses, but a consensus...
0
6
14
RT @GiuliaTurri1: Proud to share our new article!. 📝 comprehensive review of a rapidly evolving topic.💪🏻 pCR with TNT.‼️should we change ou….
0
2
0
RT @YutakaEndoSurg: New paper from @timpawlik group🚨. #AI synthesizes vast data for decision support, uses ML & NLP for insights, enhances….
0
4
0
RT @HPBVerona: Portal stenting in recurrent or locally advanced pCCA!. - Safe & Feasible (💯% success rate!, 13% overall complications) 💪.-….
0
4
0
RT @HPBVerona: RUN FOR SURGERY, RUN FOR LIFE! .Today our unit is running the StraVerona, a charity run through the streets of our beautiful….
0
4
0
RT @conci_simone: Si apre il 04 Marzo una serie di aggiornamenti sui Tumori Epato-Biliari rivolti a Medici di base, Specialisti, Medici in….
0
4
0